Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My Take

maybe since we can't sell our 50mmp outright, or get bought out; we could do a unique business resolution with our 50 steared towards new technology, not unlike what tpl is doing with sony, n possibly any of the damn j's.

 

I was suprised to see 'existing tech' in the letter as much as the strand dividend mentions.

If the right one proposed it TPL could favor it -

 

e

 

Share
New Message
Please login to post a reply